CNBX Pharmaceuticals (CNBX) News Today → Thousands of investors use this no cost solution | Do you? (From Insider Financial) (Ad) Free CNBX Stock Alerts $0.01 0.00 (0.00%) (As of 04/23/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartFinancialsSEC FilingsShort InterestStock AnalysisChartFinancialsSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineCNBX Pharmaceuticals Stock (OTC:CNBX) Dividends: History, Yield and Datesbenzinga.com - November 24 at 7:56 AMCNBX Pharmaceuticals Inc CNBXmorningstar.com - November 5 at 2:26 PMCNBX Historical Datainvesting.com - October 10 at 12:42 AMCNBX - CNBX Pharmaceuticals Inc.finance.yahoo.com - July 28 at 11:43 PMCNBX Acquires A Controlling Interest In Cancer Immunotherapy Developerbenzinga.com - November 8 at 3:58 PMCNBX to Enter the Cancer Immunotherapy Market After Acquiring a Controlling Interest in TaGeza Biopharmafinance.yahoo.com - November 8 at 10:56 AMCNBX Files New PCT Patent Application For Cannabinoids-Based Neoadjuvant Cancer Therapyfinance.yahoo.com - October 18 at 6:19 PMCNBX Patent Application "Composition and Method for Treating Cancer with Cannabinoids" Enters National Phase in US and Israelfinance.yahoo.com - October 13 at 11:58 AMCNBX Pharmaceuticals Announces New Patent Granted in Australiafinance.yahoo.com - September 28 at 10:12 AMCNBX Pharmaceuticals Increuters.com - September 12 at 10:07 PMCNBX Pharmaceuticals Inc. (CNBX)ca.finance.yahoo.com - August 16 at 8:20 PMCNBX Pharmaceuticals (OTC:CNBXD), Earnings Estimates, EPS, and Revenuebenzinga.com - June 10 at 9:56 AMCNBX Pharmaceuticals (OTC:CNBXD), Analyst Ratings, Price Targets, Predictionsbenzinga.com - June 10 at 9:56 AMCNBX Pharmaceuticals Inc. (CNBXD)finance.yahoo.com - June 7 at 9:09 PMCNBX Pharmaceuticals Release a New Corporate Presentationfinance.yahoo.com - May 31 at 11:31 AMCNBX Pharmaceuticals Inc.barrons.com - May 14 at 9:19 PMCNBX pharma granted patent in Hong Kong for cancer therapyseekingalpha.com - May 5 at 2:39 PMCNBX Pharmaceuticals Granted Patent in Hong Kongfinance.yahoo.com - May 5 at 9:26 AMNovartis to save at least $1 billion by 2024 thanks to simplified structuremsn.com - April 4 at 6:24 PMVertex Pharma sees positive results in Phase 2 trials of new non-opioid pain killermsn.com - April 4 at 6:24 PMWhat to watch today: Wall Street looks higher; Twitter soars on Elon Musk stakecnbc.com - April 4 at 9:20 AMStocks making the biggest moves in the premarket: Twitter, Tesla, Starbucks and moremsn.com - April 4 at 9:20 AMCNBC Transcript: Johnson & Johnson CEO Joaquin Duato Speaks with CNBC’s Meg Tirrell Live During CNBC’s Healthy Returns Summit Todaycnbc.com - April 1 at 4:04 PMWhat to watch today: Wall Street set to wrap up strong month but weak quartercnbc.com - April 1 at 4:04 PMStocks making the biggest moves premarket: Walgreens, Baidu, Novavax and othersmsn.com - April 1 at 4:04 PMVertex Pharmaceuticals reports positive data on non-opioid pain medicinemsn.com - April 1 at 4:04 PMCannabics Pharmaceuticals Changes Name to CNBX Pharmaceuticalsfinance.yahoo.com - March 28 at 6:44 PMAvicanna To Bring Its Cannabinoid-Based Drugs To Argentina Via 'Established' Pharma Partnerbenzinga.com - November 30 at 6:44 PMCNBX Selects API Supplier Purisys to Support Planned IND Fillings and Phase I/II (a) Clinical Trialsfinance.yahoo.com - November 4 at 12:40 PMMeet CNBX at Radiation Therapy Conference (RTC) 2021 in Chicagofinance.yahoo.com - October 26 at 2:02 PMRadiation Oncology Expert Joins Cannabics Pharmaceuticals' Board of Advisorsfinance.yahoo.com - October 25 at 12:42 PMEDISON Publishes Healthcare QuickView on Cannabics Pharmaceuticals: CNBXprnewswire.com - October 21 at 8:44 AMCEO of Cannabics Pharmaceuticals, Eyal Barad, to present at Edison Open Forum: Cannabinoids 2021finance.yahoo.com - October 19 at 2:31 PMCannabics Pharmaceuticals Files 2 Provisional Patents On Compositions and Methods for Treating Cancerfinance.yahoo.com - October 18 at 1:24 PMCEO Eyal Barad and Dr. David Sans from Cannabics Pharmaceuticals in NYC, to Participate at Benzinga's Cannabis Capital Conference | Morningstarmorningstar.com - October 14 at 2:25 PMCEO Eyal Barad and Dr. David Sans from Cannabics Pharmaceuticals in NYC, to Participate at Benzinga's Cannabis Capital Conferencefinance.yahoo.com - October 14 at 9:25 AMCannabics Announces New Corporate Logo, New Website and New Company Presentationfinance.yahoo.com - September 30 at 11:05 AMGabriel Yariv, Executive Director of Cannabics Pharmaceuticals and Dr. David Sans will participate at the ICDP Summit in Bostonfinance.yahoo.com - September 22 at 12:26 PMCannabics Pharmaceuticals hires Healthcare Investment Banker Dr. David Sans in New York to expand CNBX in Mental Health Diseasesfinance.yahoo.com - September 21 at 10:57 AMNeuropsychiatry Expert Dr. Ilya Reznik (MD) Joins Cannabics as Head of Psychedelic Inspired Medicinefinance.yahoo.com - September 13 at 9:15 AMHemato-Oncology Expert, Dr. Sigal Tavor (MD) Joins Cannabics Pharmaceuticals' Board of Advisorsfinance.yahoo.com - August 23 at 3:44 PMJ&J's Janssen Denied Data Protection Rights For Ketamine Analog Spravato In Canada, Court Rules 'Not An Innovative Drug'benzinga.com - August 10 at 10:54 PMWorld-Renowned Melanoma Expert Joins Cannabics Pharmaceuticals' Board of Advisorsfinance.yahoo.com - August 4 at 8:45 AMClever Leaves And Biopharma Research Co. Will Study DNA Sequencing Of Cannabis Under 'Project Change Lives' Initiativebenzinga.com - July 28 at 7:18 PMNew Cannabis Products: A Professional Cosmetic Line, A CBD Sports Recovery Line And Marine Collagebenzinga.com - July 23 at 11:58 PMWill Psychedelics Continue To Grow In 2021? Fund Managers Share Insights And Strategies As More Companies Go Publicbenzinga.com - July 23 at 6:58 PM Get CNBX Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CNBX and its competitors with MarketBeat's FREE daily newsletter. Email Address The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet. See how you can invest alongside him CNBX Media Mentions By Week CNBX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CNBX News Sentiment▼0.000.44▲Average Medical News Sentiment CNBX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CNBX Articles This Week▼00▲CNBX Articles Average Week Get CNBX Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CNBX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AGNPF News AKBLF News DRTSW News ARNI News ARTLW News ASCLF News AWKNF News AXIM News BRRGF News BCTXW News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:CNBX) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersSHOCKING Crypto Leak…Crypto 101 Mediatop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsThe #1 Crypto for 2024InvestorPlaceMan Who Predicted 2008: “This Will be Worse.”AltimetryBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CNBX Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
